Respiratory Anti-Ro52 Autoantibodies’ Role in Autoimmune Disorders, Inflammatory Myopathies, and Interstitial Lung DiseaseModulator Therapy of F508 deletion in the Cystic Fibrosis Transmembrane Conductance RegulatorInhibition of PDE4 and PI3Kδ in Addition to Stimulation of Nuclear Hormone Receptor PPAR in Emphysema Caused By SmokingMesenchymal Stem Cells as a Treatment for Acute Respiratory Distress SyndromeHost Inspired Reduction of Biofilm Formation in Chronic Pseudomonas aeruginosa InfectionExploration of Novel Anti-Quorum Sensing Compounds in Pseudomonas Aeruginosa Inhabited Cystic Fibrosis PatientsMesenchymal Stem Cells Suppress T-Cell Activation/Proliferation via PD-1/PD-L1 in Fibrotic Conditions such as Systemic Sclerosis.The Role of WNT5a as a Regulator of Cystic Airspace Enlargement in Pulmonary LymphangioleiomyomatosisThe Role of WNT5a as a Regulator of Cystic Airspace Enlargement in Pulmonary LymphangioleiomyomatosisThe Role of 5-HT2B Receptor Antagonism in the Prevention of Idiopathic Pulmonary Fibrosis